(Q51604935)

English

Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism

scientific article published on July 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1642149

Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism (English)

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Orthopedics and sports medicine

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

author name string

K. K. Ho

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642149

20 October 2022

A. J. Weissberger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642149

20 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1642149

20 October 2022

publication date

1 July 1992

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1642149

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjbmr.5650070711

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/jbmr.5650070711

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1642149

7

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1642149

7

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1642149

821-827

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1642149

Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650070711

21 January 2018

Comparison of pharmacodynamic properties of various estrogen formulations

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650070711

21 January 2018

Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650070711

21 January 2018

Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations

1

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women

2

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Radioimmunoassay for type I procollagen in growth hormone-deficient children before and during treatment with growth hormone

3

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy

4

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen

6

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Serum bone GLA-protein in growth hormone deficient children

7

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy

8

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Effects of short term administration of recombinant human growth hormone to elderly people

9

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Identification of a Receptor for Somatomedin-Like Polypeptides in Human Fibroblasts*

10

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts

11

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Characterization of Insulin-Like Growth Factor I Receptors on Cultured Rat Bone Cells: Regulation of Receptor Concentration by Glucocorticoids*

12

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria

13

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats

14

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production

15

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Insulin-like growth factor I has independent effects on bone matrix formation and cell replication

16

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects

17

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Age and menopause-related changes in indices of bone turnover

20

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.

21

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis

22

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Serum Levels of Type I and III Procollagen Fragments in Paget's Disease of Bone*

23

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase

24

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Mode of action of pituitary growth hormone on target cells

25

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

26

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Visual Demonstration of Growth Hormone Receptors on Human Growth Plate Chondrocytes*

27

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH.

28

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Growth hormone potentiates colony formation of epiphyseal chondrocytes in suspension culture

29

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Identification and characterization of specific binding proteins for growth hormone in normal human sera

30

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

A specific growth hormone-binding protein in human plasma: initial characterization

31

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats

33

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Evidence of estrogen receptors in normal human osteoblast-like cells

34

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones

35

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.

36

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells

37

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Biologic effects of transdermal estradiol

40

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

41

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Effects of a short course of estrogen on mineral metabolism in postmenopausal women.

42

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Effects of transdermal estrogen replacement on parathyroid hormone secretion.

43

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Serum and urinary markers of bone remodeling: assessment of bone turnover

44

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women

45

1 reference

10.1002/JBMR.5650070711

https://api.crossref.org/works/10.1002/JBMR.5650070711

20 October 2022

Identifiers

10.1002/JBMR.5650070711

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1642149

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1642149

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51604935&oldid=1754707272"